Abivax S.A. (AAVXF) Financials

AAVXF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 527.5 million 109.5 million
March 31, 2026 627.0 million 134.7 million
Dec. 31, 2025 685.7 million 151.5 million
Sept. 30, 2025 765.2 million 165.2 million

AAVXF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -59.5 million 19.2 million
March 31, 2026 -58.0 million 25.9 million
Dec. 31, 2025 -83.7 million -12.9 million
Sept. 30, 2025 -83.6 million 13.5 million

AAVXF Net Income

No data available :(

AAVXF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 468.7 million - 1.4 million
March 31, 2026 - - 1.7 million
Dec. 31, 2025 622.4 million 35.5 million 1.8 million
Sept. 30, 2025 - - 1.8 million

AAVXF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 90.9 million
March 31, 2026 90.9 million
Dec. 31, 2025 81.6 million
Sept. 30, 2025 91.3 million

AAVXF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 127823 66.6 million 30.8 million 116410
March 31, 2026 61881 56.8 million 9.2 million -
Dec. 31, 2025 9391 117.1 million 32.5 million 24653
Sept. 30, 2025 - 65.0 million 32.1 million -

AAVXF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 -2.4 million 1.3 million
Sept. 30, 2025 - -

AAVXF

Price: $139

52 week price:
71.26
139.00

Earnings Per Share: -6.06 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 10.2 billion

Links: